Paper24252773
Results of bronchial artery embolization for the treatment of hemoptysis caused by neoplasm.
Garcia-Olivé I and 9 others. J Vasc Interv Radiol, 2014. Cited by 41 papers, by iCite.
Cite this record
ConductScience Library. Results of bronchial artery embolization for the treatment of hemoptysis caused by neoplasm. Papers, record 24252773. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24252773
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Results of bronchial artery embolization for the treatment of hemoptysis caused by neoplasm.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bronchial Arteries | Major topic |
| Embolization, Therapeutic | Major topic |
| Hemoptysis | Major topic |
| Lung Neoplasms | Major topic |
| Aged | |
| Disease Progression | |
| Female | |
| Humans | |
| Kaplan-Meier Estimate | |
| Male | |
| Middle Aged | |
| Radiography | |
| Recurrence | |
| Retrospective Studies | |
| Risk Factors | |
| Time Factors | |
| Treatment Outcome |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42170297 | International Consensus on Severe Lung Cancer-The Second Edition. | Transl Lung Cancer Res | 2026 | https://conductscience.org/library/papers/42170297 | PubMed |
| 40936993 | Risk factors of hemoptysis recurrence after bronchial artery embolization and patient feedbacks. | Turk Gogus Kalp Damar Cerrahisi Derg | 2025 | https://conductscience.org/library/papers/40936993 | PubMed |
| 40735168 | Bronchial artery embolization for haemoptysis in patients with lymphoma and leukaemia. | BJR Case Rep | 2025 | https://conductscience.org/library/papers/40735168 | PubMed |
| 40113741 | Severe hemoptysis associated with lung cancer in the ICU: recurrence and outcome. | Ann Intensive Care | 2025 | https://conductscience.org/library/papers/40113741 | PubMed |
| 39423778 | Non-emergent hemoptysis in patients with primary or metastatic lung tumors: The role of transarterial embolization. | Eur J Radiol | 2024 | https://conductscience.org/library/papers/39423778 | PubMed |
| 38003912 | Pulmonary Artery Embolization in the Management of Hemoptysis Related to Lung Tumors. | J Pers Med | 2023 | https://conductscience.org/library/papers/38003912 | PubMed |
| 37835458 | Hemoptysis in Cancer Patients. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37835458 | PubMed |
| 37311841 | Endovascular Management of Life-Threatening Hemoptysis in Primary Lung Cancer: A Retrospective Study. | Cardiovasc Intervent Radiol | 2023 | https://conductscience.org/library/papers/37311841 | PubMed |
| 36591505 | Case Report: Bronchial artery embolization and chemoradiotherapy for central squamous cell lung carcinoma with rapid regression. | Front Oncol | 2022 | https://conductscience.org/library/papers/36591505 | PubMed |
| 36127690 | Comparison of n-butyl-2-cyanoacrylate and polyvinyl alcohol particles for bronchial artery embolisation in primary lung cancer: a retrospective cohort study. | Respir Res | 2022 | https://conductscience.org/library/papers/36127690 | PubMed |
| 36062230 | Advancements in Interventional Oncology of the Chest: Transarterial Chemoembolization and Related Therapies. | Semin Intervent Radiol | 2022 | https://conductscience.org/library/papers/36062230 | PubMed |
| 35484185 | Bronchial artery embolization for hemoptysis caused by metastatic hepatocellular carcinoma. | Sci Rep | 2022 | https://conductscience.org/library/papers/35484185 | PubMed |
| 34362373 | Feasibility and outcomes of bronchial artery embolization in patients with non-massive hemoptysis. | Respir Res | 2021 | https://conductscience.org/library/papers/34362373 | PubMed |
| 33855367 | Transarterial management of advance lung cancer. | Jpn J Clin Oncol | 2021 | https://conductscience.org/library/papers/33855367 | PubMed |
| 31435125 | Embolization of Chest Neoplasms: The Next Frontier in Interventional Oncology? | Semin Intervent Radiol | 2019 | https://conductscience.org/library/papers/31435125 | PubMed |
| 31123382 | Anterior Cord Syndrome after Embolization for Malignant Hemoptysis. | Semin Intervent Radiol | 2019 | https://conductscience.org/library/papers/31123382 | PubMed |
| 29249863 | Palliative Embolization for Refractory Bleeding. | Semin Intervent Radiol | 2017 | https://conductscience.org/library/papers/29249863 | PubMed |
| 28942519 | An applied anatomical study of bronchial artery. | Surg Radiol Anat | 2018 | https://conductscience.org/library/papers/28942519 | PubMed |
| 28608003 | Transarterial chemoembolization for management of hemoptysis: initial experience in advanced primary lung cancer patients. | Jpn J Radiol | 2017 | https://conductscience.org/library/papers/28608003 | PubMed |
| 26380767 | Bronchial artery embolization for malignant hemoptysis: a single institutional experience. | J Thorac Dis | 2015 | https://conductscience.org/library/papers/26380767 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24252773
GET https://conductscience.org/api/papers/v1/24252773/authors